{"id":5596,"date":"2025-04-18T15:06:23","date_gmt":"2025-04-18T14:06:23","guid":{"rendered":"https:\/\/movianto.com\/fr\/?post_type=news&#038;p=5596"},"modified":"2025-04-18T15:06:23","modified_gmt":"2025-04-18T14:06:23","slug":"confronting-challenges-in-europes-largest-pharma-market","status":"publish","type":"news","link":"https:\/\/movianto.com\/fr\/toutes-les-actualites\/confronting-challenges-in-europes-largest-pharma-market\/","title":{"rendered":"Relever les d\u00e9fis du plus grand march\u00e9 pharmaceutique d&#8217;Europe : Entretien avec Dennis Spamer, Directeur G\u00e9n\u00e9ral de Movianto DACH"},"excerpt":{"rendered":"Dans cet entretien, Dennis met l&#8217;accent sur l&#8217;orientation strat\u00e9gique et la d\u00e9l\u00e9gation, puis nous partage ses connaissances du march\u00e9 de la sant\u00e9 dans la r\u00e9gion DACH ainsi que ses d\u00e9fis.","protected":false},"featured_media":5597,"parent":0,"template":"","acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.5 (Yoast SEO v24.5) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Relever les d\u00e9fis du plus grand march\u00e9 pharmaceutique d&#039;Europe : Entretien avec Dennis Spamer, Directeur G\u00e9n\u00e9ral de Movianto DACH - FR<\/title>\n<meta name=\"description\" content=\"Dans cet entretien, il met l&#039;accent sur l&#039;orientation strat\u00e9gique et la d\u00e9l\u00e9gation, puis nous partage ses connaissances du march\u00e9 de la sant\u00e9 dans la r\u00e9gion DACH ainsi que ses d\u00e9fis.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/movianto.com\/fr\/toutes-les-actualites\/confronting-challenges-in-europes-largest-pharma-market\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Relever les d\u00e9fis du plus grand march\u00e9 pharmaceutique d&#039;Europe : Entretien avec Dennis Spamer, Directeur G\u00e9n\u00e9ral de Movianto DACH\" \/>\n<meta property=\"og:description\" content=\"Dans cet entretien, il met l&#039;accent sur l&#039;orientation strat\u00e9gique et la d\u00e9l\u00e9gation, puis nous partage ses connaissances du march\u00e9 de la sant\u00e9 dans la r\u00e9gion DACH ainsi que ses d\u00e9fis.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/movianto.com\/fr\/toutes-les-actualites\/confronting-challenges-in-europes-largest-pharma-market\/\" \/>\n<meta property=\"og:site_name\" content=\"FR\" \/>\n<meta property=\"og:image\" content=\"https:\/\/movianto.com\/fr\/wp-content\/uploads\/sites\/2\/2025\/04\/ETPTPI-YouTube.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/movianto.com\/fr\/toutes-les-actualites\/confronting-challenges-in-europes-largest-pharma-market\/\",\"url\":\"https:\/\/movianto.com\/fr\/toutes-les-actualites\/confronting-challenges-in-europes-largest-pharma-market\/\",\"name\":\"Relever les d\u00e9fis du plus grand march\u00e9 pharmaceutique d'Europe : Entretien avec Dennis Spamer, Directeur G\u00e9n\u00e9ral de Movianto DACH - FR\",\"isPartOf\":{\"@id\":\"https:\/\/movianto.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/movianto.com\/fr\/toutes-les-actualites\/confronting-challenges-in-europes-largest-pharma-market\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/movianto.com\/fr\/toutes-les-actualites\/confronting-challenges-in-europes-largest-pharma-market\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/movianto.com\/fr\/wp-content\/uploads\/sites\/2\/2025\/04\/ETPTPI-YouTube.jpg\",\"datePublished\":\"2025-04-18T14:06:23+00:00\",\"description\":\"Dans cet entretien, il met l'accent sur l'orientation strat\u00e9gique et la d\u00e9l\u00e9gation, puis nous partage ses connaissances du march\u00e9 de la sant\u00e9 dans la r\u00e9gion DACH ainsi que ses d\u00e9fis.\",\"breadcrumb\":{\"@id\":\"https:\/\/movianto.com\/fr\/toutes-les-actualites\/confronting-challenges-in-europes-largest-pharma-market\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/movianto.com\/fr\/toutes-les-actualites\/confronting-challenges-in-europes-largest-pharma-market\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/movianto.com\/fr\/toutes-les-actualites\/confronting-challenges-in-europes-largest-pharma-market\/#primaryimage\",\"url\":\"https:\/\/movianto.com\/fr\/wp-content\/uploads\/sites\/2\/2025\/04\/ETPTPI-YouTube.jpg\",\"contentUrl\":\"https:\/\/movianto.com\/fr\/wp-content\/uploads\/sites\/2\/2025\/04\/ETPTPI-YouTube.jpg\",\"width\":1280,\"height\":720,\"caption\":\"Dennis Spamer portrait shoulders up smiles at the camera with the Movianto logo next to him\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/movianto.com\/fr\/toutes-les-actualites\/confronting-challenges-in-europes-largest-pharma-market\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/movianto.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Relever les d\u00e9fis du plus grand march\u00e9 pharmaceutique d&#8217;Europe : Entretien avec Dennis Spamer, Directeur G\u00e9n\u00e9ral de Movianto DACH\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/movianto.com\/fr\/#website\",\"url\":\"https:\/\/movianto.com\/fr\/\",\"name\":\"FR\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/movianto.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/movianto.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/movianto.com\/fr\/#organization\",\"name\":\"FR\",\"url\":\"https:\/\/movianto.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/movianto.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/movianto.com\/fr\/wp-content\/uploads\/sites\/2\/2023\/03\/Movianto-news-photos-9.jpg\",\"contentUrl\":\"https:\/\/movianto.com\/fr\/wp-content\/uploads\/sites\/2\/2023\/03\/Movianto-news-photos-9.jpg\",\"width\":600,\"height\":424,\"caption\":\"FR\"},\"image\":{\"@id\":\"https:\/\/movianto.com\/fr\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Relever les d\u00e9fis du plus grand march\u00e9 pharmaceutique d'Europe : Entretien avec Dennis Spamer, Directeur G\u00e9n\u00e9ral de Movianto DACH - FR","description":"Dans cet entretien, il met l'accent sur l'orientation strat\u00e9gique et la d\u00e9l\u00e9gation, puis nous partage ses connaissances du march\u00e9 de la sant\u00e9 dans la r\u00e9gion DACH ainsi que ses d\u00e9fis.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/movianto.com\/fr\/toutes-les-actualites\/confronting-challenges-in-europes-largest-pharma-market\/","og_locale":"en_GB","og_type":"article","og_title":"Relever les d\u00e9fis du plus grand march\u00e9 pharmaceutique d'Europe : Entretien avec Dennis Spamer, Directeur G\u00e9n\u00e9ral de Movianto DACH","og_description":"Dans cet entretien, il met l'accent sur l'orientation strat\u00e9gique et la d\u00e9l\u00e9gation, puis nous partage ses connaissances du march\u00e9 de la sant\u00e9 dans la r\u00e9gion DACH ainsi que ses d\u00e9fis.","og_url":"https:\/\/movianto.com\/fr\/toutes-les-actualites\/confronting-challenges-in-europes-largest-pharma-market\/","og_site_name":"FR","og_image":[{"width":1280,"height":720,"url":"https:\/\/movianto.com\/fr\/wp-content\/uploads\/sites\/2\/2025\/04\/ETPTPI-YouTube.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/movianto.com\/fr\/toutes-les-actualites\/confronting-challenges-in-europes-largest-pharma-market\/","url":"https:\/\/movianto.com\/fr\/toutes-les-actualites\/confronting-challenges-in-europes-largest-pharma-market\/","name":"Relever les d\u00e9fis du plus grand march\u00e9 pharmaceutique d'Europe : Entretien avec Dennis Spamer, Directeur G\u00e9n\u00e9ral de Movianto DACH - FR","isPartOf":{"@id":"https:\/\/movianto.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/movianto.com\/fr\/toutes-les-actualites\/confronting-challenges-in-europes-largest-pharma-market\/#primaryimage"},"image":{"@id":"https:\/\/movianto.com\/fr\/toutes-les-actualites\/confronting-challenges-in-europes-largest-pharma-market\/#primaryimage"},"thumbnailUrl":"https:\/\/movianto.com\/fr\/wp-content\/uploads\/sites\/2\/2025\/04\/ETPTPI-YouTube.jpg","datePublished":"2025-04-18T14:06:23+00:00","description":"Dans cet entretien, il met l'accent sur l'orientation strat\u00e9gique et la d\u00e9l\u00e9gation, puis nous partage ses connaissances du march\u00e9 de la sant\u00e9 dans la r\u00e9gion DACH ainsi que ses d\u00e9fis.","breadcrumb":{"@id":"https:\/\/movianto.com\/fr\/toutes-les-actualites\/confronting-challenges-in-europes-largest-pharma-market\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/movianto.com\/fr\/toutes-les-actualites\/confronting-challenges-in-europes-largest-pharma-market\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/movianto.com\/fr\/toutes-les-actualites\/confronting-challenges-in-europes-largest-pharma-market\/#primaryimage","url":"https:\/\/movianto.com\/fr\/wp-content\/uploads\/sites\/2\/2025\/04\/ETPTPI-YouTube.jpg","contentUrl":"https:\/\/movianto.com\/fr\/wp-content\/uploads\/sites\/2\/2025\/04\/ETPTPI-YouTube.jpg","width":1280,"height":720,"caption":"Dennis Spamer portrait shoulders up smiles at the camera with the Movianto logo next to him"},{"@type":"BreadcrumbList","@id":"https:\/\/movianto.com\/fr\/toutes-les-actualites\/confronting-challenges-in-europes-largest-pharma-market\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/movianto.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Relever les d\u00e9fis du plus grand march\u00e9 pharmaceutique d&#8217;Europe : Entretien avec Dennis Spamer, Directeur G\u00e9n\u00e9ral de Movianto DACH"}]},{"@type":"WebSite","@id":"https:\/\/movianto.com\/fr\/#website","url":"https:\/\/movianto.com\/fr\/","name":"FR","description":"","publisher":{"@id":"https:\/\/movianto.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/movianto.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/movianto.com\/fr\/#organization","name":"FR","url":"https:\/\/movianto.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/movianto.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/movianto.com\/fr\/wp-content\/uploads\/sites\/2\/2023\/03\/Movianto-news-photos-9.jpg","contentUrl":"https:\/\/movianto.com\/fr\/wp-content\/uploads\/sites\/2\/2023\/03\/Movianto-news-photos-9.jpg","width":600,"height":424,"caption":"FR"},"image":{"@id":"https:\/\/movianto.com\/fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/movianto.com\/fr\/wp-json\/wp\/v2\/news\/5596"}],"collection":[{"href":"https:\/\/movianto.com\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/movianto.com\/fr\/wp-json\/wp\/v2\/types\/news"}],"version-history":[{"count":1,"href":"https:\/\/movianto.com\/fr\/wp-json\/wp\/v2\/news\/5596\/revisions"}],"predecessor-version":[{"id":5600,"href":"https:\/\/movianto.com\/fr\/wp-json\/wp\/v2\/news\/5596\/revisions\/5600"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/movianto.com\/fr\/wp-json\/wp\/v2\/media\/5597"}],"wp:attachment":[{"href":"https:\/\/movianto.com\/fr\/wp-json\/wp\/v2\/media?parent=5596"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}